• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Mesa Laboratories Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    6/6/25 3:00:33 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials
    Get the next $MLAB alert in real time by email
    mlab20250603_8k.htm
    false 0000724004 0000724004 2025-06-03 2025-06-03
     


     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549   
     
    FORM 8-K
     
    CURRENT REPORT
     
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
     
    Date of Report (Date of earliest event reported): June 3, 2025
     
    MESA LABORATORIES, INC.
    (Exact name of registrant as specified in its charter)
     
    Colorado
    (State or other jurisdiction of
    incorporation)
    0-11740
    (Commission File Number)
    84-0872291
    (I.R.S. Employer
    Identification No.)
     
    12100 West Sixth Avenue,
    Lakewood, Colorado
    (Address of principal executive offices)
     
    80228
    (Zip Code)
     
    Registrant’s telephone number, including area code: 303-987-8000
     
    Not Applicable
    (Former name or former address, if changed since last report)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
     
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
     
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
     
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered under Section 12(b) of the Act:
     
    Title of each class
     
    Trading Symbol
     
    Name of each exchange on which
    registered
             
    Common Stock, no par value
     
    MLAB
     
    The Nasdaq Stock Market LLC
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
     
    Emerging growth company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
     


     
     

     
     
    Item 4.01.
    Changes in Registrant’s Certifying Accountant.
     
     
    On June 3, 2025, Mesa Laboratories, Inc., (the "Company") was notified that Moss Adams LLP ("Moss Adams"), the Company's independent registered public accounting firm, merged with Baker Tilly US, LLP effective on June 3, 2025. The combined audit practices operate as Baker Tilly US, LLP (“Baker Tilly”). In connection with the notification of the merger, Moss Adams has resigned as the auditors of the Company and the Audit Committee of the Company’s Board of Directors approved the appointment of Baker Tilly, as the successor to Moss Adams, as the Company’s independent registered public accounting firm.
     
    The audit report of Moss Adams on the Company’s consolidated financial statements as of March 31, 2025, and for the year then ended, and internal control over financial reporting as of March 31, 2025, did not contain an adverse opinion or a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principles.
     
    During the year ended March 31, 2025, and the subsequent interim period through June 3, 2025, there were no (a) disagreements with Moss Adams on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which, if not resolved to Moss Adams’ satisfaction, would have caused it to make reference to the subject matter of the disagreement in connection with its reports on the Company’s financial statements, or (b) reportable events requiring disclosure pursuant to Item 304(a)(1)(v) of Regulation S-K.
     
    During the year ended March 31, 2025, and the subsequent interim period through the date of this Current Report on Form 8-K, neither the Company, nor anyone on its behalf, consulted with Baker Tilly regarding: (i) either the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements; or (ii) any matter that was either the subject of a “disagreement,” as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions to that item, or a “reportable event,” as described in Item 304(a)(1)(v) of Regulation S-K.
     
    The Company provided Moss Adams with a copy of this Current Report on Form 8-K prior to its filing with the Securities and Exchange Commission (the “Commission”) and requested that Moss Adams furnish the Company with a letter addressed to the Commission stating whether it agrees with the above statements and, if it does not agree, the respects in which it does not agree. A copy of Moss Adams’ letter to the Commission, dated June 3, 2025, is filed as Exhibit 16.1 to this Form 8-K and is incorporated herein by reference.
     
    Item 9.01.
    Financial Statements and Exhibits.
     
    (d)  Exhibits.
     
    Exhibit No.
     
    Description
    16.1
     
    Letter from Moss Adams Dated June 5, 2025
    104   Cover Page Interactive Data File (imbedded within the Inline XBRL document)
     
     

     
     
    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
     
    DATE: June 6, 2025
     
    Mesa Laboratories, Inc.
       
    (Registrant)
         
         
     
    BY: 
    /s/ Gary M. Owens  
       
    Gary M. Owens
       
    President and Chief Executive Officer
     
     
     
    Get the next $MLAB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MLAB

    DatePrice TargetRatingAnalyst
    8/28/2024$120.00Underweight
    Wells Fargo
    1/4/2024$100.00 → $125.00In-line → Outperform
    Evercore ISI
    More analyst ratings

    $MLAB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results

      LAKEWOOD, Colo., May 28, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter ("4Q25") and full fiscal year ("FY25") ended March 31, 2025 (amounts in thousands). Fourth quarter FY25 compared to fourth quarter FY24: Revenues increased 5.5%Non-GAAP core organic revenues growth1 was 6.3%Operating income increased 100.5% to $1,469Non-GAAP adjusted operating income ("AOI") excluding unusual items2 decreased 18.0% and was 19.7% as a percentage of revenues   Full FY25 compared to full FY24:

      5/28/25 8:00:16 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • MESA LABS DECLARES QUARTERLY DIVIDEND

      LAKEWOOD, Colo., April 07, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase p

      4/7/25 3:00:00 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Labs Announces Third Quarter Results

      LAKEWOOD, Colo., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its third fiscal quarter ("3Q25") ended December 31, 2024 (amounts in thousands). Third quarter FY 2025 compared to third quarter FY 2024: Revenues increased 17.5%Non-GAAP core organic revenues1 increase was 13.2%Operating income increased 8,725% to $5,779Non-GAAP adjusted operating income excluding unusual items2 increased 13.3% and was 23.5% as a percentage of revenues We operate our business in four divisions: Sterilization and Disinfection Control ("SDC"

      2/4/25 8:00:38 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    Financials

    Live finance-specific insights

    See more
    • MESA LABS DECLARES QUARTERLY DIVIDEND

      LAKEWOOD, Colo., April 07, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase p

      4/7/25 3:00:00 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • MESA LABS DECLARES QUARTERLY DIVIDEND

      LAKEWOOD, Colo., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 17, 2025, to shareholders of record at the close of business on February 28, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increa

      1/6/25 3:00:00 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • MESA LABS DECLARES QUARTERLY DIVIDEND

      LAKEWOOD, Colo., Oct. 02, 2024 (GLOBE NEWSWIRE) --  Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, in

      10/2/24 2:00:00 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Mesa Laboratories Inc.

      SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

      10/15/24 1:29:56 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

      SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

      2/13/24 5:09:39 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

      SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

      1/23/24 2:18:26 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President and CEO Owens Gary M exercised 21,000 shares at a strike of $122.98 and sold $2,602,110 worth of shares (21,000 units at $123.91) (SEC Form 4)

      4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

      3/24/25 1:38:04 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Director Sullivan John James gifted 2,000 shares, decreasing direct ownership by 7% to 25,878 units (SEC Form 4)

      4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

      11/25/24 11:40:41 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • President and CEO Owens Gary M was granted 11,559 shares and sold $571,736 worth of shares (5,069 units at $112.79), increasing direct ownership by 18% to 43,337 units (SEC Form 4)

      4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

      10/29/24 8:18:57 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Wells Fargo initiated coverage on Mesa Laboratories with a new price target

      Wells Fargo initiated coverage of Mesa Laboratories with a rating of Underweight and set a new price target of $120.00

      8/28/24 7:48:06 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Laboratories upgraded by Evercore ISI with a new price target

      Evercore ISI upgraded Mesa Laboratories from In-line to Outperform and set a new price target of $125.00 from $100.00 previously

      1/4/24 8:29:10 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    SEC Filings

    See more
    • Mesa Laboratories Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

      8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

      6/6/25 3:00:33 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • SEC Form 10-K filed by Mesa Laboratories Inc.

      10-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

      5/28/25 8:01:28 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

      5/28/25 8:00:10 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials

    $MLAB
    Leadership Updates

    Live Leadership Updates

    See more
    • Mesa Laboratories Appoints Mark Capone to its Board of Directors

      LAKEWOOD, Colo., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa", "we", "us", or "our"), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced the appointment of Mark Capone to its Board of Directors (the "Board"), effective January 5, 2024. Dr. John Sullivan, Ph.D., Chairman of the Board of Directors, stated: "We are pleased to welcome Mark to Mesa's Board. Mark is an accomplished life sciences executive with significant leadership and acquisitions experience spanning biopharmaceuticals, life science tools, and clinical genomics. We believe Mark's insights will be pivotal to Mesa

      1/8/24 8:00:00 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director

      LAKEWOOD, Colo., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa" or the "Company") today announced that Shiraz Ladiwala has been appointed to serve as the Lead Independent Director of its Board of Directors ("Board"), effective November 3, 2022. Mr. Ladiwala assumes this newly re-created role as an expansion of his current responsibilities on the Board, on which he has served since October 2021. Mr. Ladiwala was selected for this important role due to the thoughtful leadership and contributions he has made to the Board as well as the exceptional breadth of his professional experience. Mr. Ladiwala said, "I am delighted to accept this leadership role on Mes

      11/4/22 3:49:04 PM ET
      $MLAB
      Industrial Machinery/Components
      Industrials
    • Mesa Laboratories Appoints Tony Tripeny to its Board of Directors

      LAKEWOOD, Colo., June 27, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) announced the appointment of Tony Tripeny to its Board of Directors (the "Board"), effective June 23, 2022. Tony was previously the Executive Vice President and Chief Financial Officer of Corning, Incorporated and retired on May 2, 2022. With Mr. Tripeny's appointment, the Mesa Laboratories, Inc. Board of Directors will be comprised of eight directors, six of whom are independent. Mr. Tripeny is likely to be appointed to the Audit Committee and brings extensive financial experience to the Board. The Board is committed to ongoing director refreshment and continues to consider new, qualified independent

      6/27/22 8:01:00 AM ET
      $MLAB
      Industrial Machinery/Components
      Industrials